Search and Filter
Results per Page:
Stuck on high alert: Altered immune responses during Long COVID
From the Newell lab, Vaccine and Infectious Disease Division
Measuring what matters in cancer clinical trials
From the Fred Hutch/UW Lymphoma-CLL Clinical Research Program, Clinical Research Division
Looking beyond survival in patients with severe aplastic anemia
From the Bhatt Lab, Clinical Research Division
Sore or silent: why do herpes outcomes differ?
From the Zhu and Corey labs, Vaccine and Infectious Disease Division
One drug, multiple targets – uncovering new uses for approved kinase inhibitors
From the Gujral Lab, Human Biology Division
Cellular traffic camera catches a pileup on the metabolic highway
From the Sullivan Lab, Human Biology Division
UPS delivery error: EEL-1/HUWE1 mutation results in proteasomal dysfunction
From the Lehrbach Lab, Basic Sciences Division
Decoding therapeutic resistance: the role of tRNAs in prostate cancer lineage plasticity
From the Hsieh Lab, Human Biology
Lessons from re-infection: Broadly neutralizing, pan-sarbecovirus antibodies elicited by repeated SARS-CoV-2 exposure
From the Overbaugh lab, Human Biology Division
New essential interactions defined in yeast kinetochore structures
From the Biggins lab, Basic Sciences Division
Tracing wildfire smoke to cancer burden reveals unexpected regional patterns
From the VoPham research group, Public Health Sciences Division
When cancer and work collide, the effects run both ways
From the Shankaran research group, Public Health Sciences Division
A new role for CAR T cells in studying the immune system
From the Peterson Lab, Translational Science and Therapeutics Division
Helping T cells find cancers hiding in plain sight
From the Chapuis Lab, Translational Science and Therapeutics Division
Surveillance scrutinized: A critical look at screening for triple negative breast cancer recurrence
From the Parsons Lab, Clinical Research Division
Artificial intelligence takes on neurodendocrine prostate cancer diagnosis
From Dr. Michael Haffner and colleagues, Human Biology and Clinical Research Divisions
Modelando el futuro de la prevención del VIH: ¿Puede una inyección aplicada dos veces al año potenciar el éxito de la PrEP?
Del Laboratorio Dimitrov, Departamento de Vacunas y Enfermedades Infecciosas
Why cancer researchers struggle to capture the patient voice
From the Jones research group, Public Health Sciences Division
Listening to Black men to understand gaps in prostate cancer screening
From the Nyame research group, Public Health Sciences Division
Prevention isn't enough: Invasive fusariosis affects cancer patients despite antifungal prophylaxis
From the Pergam Lab, Clinical Research and Vaccine Infectious Disease Divisions